| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C495657 |
1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane |
CYP2C18 protein results in increased chemical synthesis of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | increases chemical synthesis | 9733665
|
| C035342 |
1,4-naphthoquinone |
CYP2C18 protein results in increased abundance of 1,4-naphthoquinone | increases abundance | 16243959
|
| C017062 |
1-benzylimidazole |
1-benzylimidazole results in increased expression of CYP2C18 protein | increases expression | 16714371
|
| D000074 |
Acenocoumarol |
CYP2C18 gene polymorphism affects the susceptibility to Acenocoumarol | affects response to substance | 19578179
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CYP2C18 protein | affects expression | 20106945
|
| D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in decreased expression of CYP2C18 mRNA | decreases expression | 16985168
|
| D003033 |
Coal Tar |
Coal Tar results in increased expression of CYP2C18 mRNA | increases expression | 16882163
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CYP2C18 mRNA | decreases expression | 20106945
|
| D008731 |
Methoxychlor |
CYP2C18 protein results in decreased methylation of Methoxychlor | decreases methylation | 9733665
|
| D009853 |
Omeprazole |
Omeprazole results in increased expression of CYP2C18 protein | increases expression | 16714371
|
| C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of CYP2C18 mRNA | decreases expression | 17560707
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of CYP2C18 protein | increases expression | 9972451
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of CYP2C18 protein | increases expression | 16714371
|
| D011374 |
Progesterone |
Progesterone results in decreased expression of CYP2C18 mRNA | decreases expression | 18070364
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CYP2C18 mRNA | decreases expression | 16985168
|
| D014212 |
Tretinoin |
Tretinoin results in decreased expression of CYP2C18 mRNA | decreases expression | 16985168
|
| C060523 |
vorozole |
vorozole results in increased expression of CYP2C18 protein | increases expression | 16714371
|
| D014859 |
Warfarin |
CYP2C18 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 19752777
|
| D014859 |
Warfarin |
CYP2C18 protein affects the susceptibility to Warfarin | affects response to substance | 19752777
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.27 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.27 | 15322242 14514962 11752688 |
| MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
3.32 | 19389873 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
10.05 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.05 | 16835633 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.06 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Omeprazole |
15.33 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.33 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.33 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.34 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.24 | 15380490 15665606 15845082 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.86 | 15562024 16175315 17614352 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.86 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.61 | 21507988 12619106 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.61 | 20935162 17173139 6705139 1701930 20007298 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.61 | 1917145 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.28 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 16120746 18850075 18670907 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.08 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.51 | 12371664 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.24 | 4080065 |
| MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.83 | 11061249 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
| MESH:D002637 |
Chest Pain |
|
Omeprazole |
5.11 | 15447763 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.90 | 19486331 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.74 | 12621046 15340226 16354765 8697196 15668235 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.74 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 14669216 17141729 |
| MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.66 | 12872399 |
| OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.80 | 20497562 20579077 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.44 | 15322242 10048152 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.44 | 9142499 10589399 9125849 17551590 8800419 16925845 9664655 9211117 14991402 9224671 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
4.05 | 18772604 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
5.07 | 12644472 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.48 | 17187935 |
| MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.97 | 14723717 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.53 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
| MESH:D004381 |
Duodenal Ulcer |
|
Omeprazole |
4.31 | 17151854 21218061 15991576 16613094 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.99 | 1851702 |
| MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
6.88 | 17259670 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.88 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.95 | 16714409 15322242 18230668 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.95 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.76 | 17692515 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.09 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
8.87 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.87 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.09 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.87 | 3922381 11558140 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.88 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.52 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.24 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.01 | 3659116 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.78 | 9664655 16938888 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.84 | 19224547 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.65 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.65 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.65 | 17994277 |
| MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.71 | 11794436 |
| MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.94 | 12359135 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.99 | 17312396 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.17 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.50 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.50 | 14991402 9664655 |
| MESH:D006406 |
Hematoma |
|
Warfarin |
6.71 | 17493413 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
10.44 | 11000095 |
| MESH:D006470 |
Hemorrhage |
|
Warfarin |
10.44 | 18429757 |
| MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
14.46 | 3609246 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.46 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.46 | 16120746 15340226 12621046 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 8697196 16354765 16959395 15340226 18606429 |
| MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.99 | 12083418 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.99 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.92 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.92 | 18850075 18670907 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.79 | 12359135 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.39 | 15869954 |
| MESH:D007248 |
Infertility, Male |
|
Methoxychlor |
4.22 | 11955947 16467254 |
| MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
8.33 | 12083418 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
8.33 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.33 | 12200463 12878042 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.87 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.87 | 17551590 15992940 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.33 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.72 | 12371664 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Omeprazole |
4.08 | 19248655 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
2.76 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.68 | 19285840 16932348 16482212 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 17596541 19850784 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.14 | 17712046 19029980 19642359 19075265 17339181 19225113 17217047 12679006 16140955 16331271 17107899 17506722 17361223 16935935 16823087 15748426 17294898 16766008 16788101 17368321 19035177 17301526 9834237 17649720 16891316 |
| MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.22 | 8812269 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
| MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.71 | 18280355 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.88 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.30 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.30 | 18397230 16248980 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.17 | 19363144 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.18 | 2125692 9163691 18177683 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
14.18 | 19389873 21295105 |
| MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
14.18 | 18709148 14757943 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.18 | 8742319 19812893 19073162 19482888 21047994 15975961 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.18 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.03 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
14.03 | 18164116 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
14.03 | 1399818 18308698 2563599 6150874 17172636 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.03 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.29 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.29 | 11884234 19555203 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.85 | 11408345 17203775 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.07 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.47 | 17484760 |
| MESH:D009336 |
Necrosis |
|
Warfarin |
5.54 | 14723717 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.40 | 16946489 16594593 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.46 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.46 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.04 | 9142499 |
| MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.94 | 9802331 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.36 | 17016548 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.90 | 16525653 17393432 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.90 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.88 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.25 | 16965848 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.25 | 15976015 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.91 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.91 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.64 | 17132714 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.64 | 11896295 11118676 11222880 11399792 |
| MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
6.34 | 18376272 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.50 | 12752131 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
| MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
6.34 | 19300499 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.08 | 16283617 16116481 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.85 | 18045962 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
2.68 | 11442880 3137016 4039156 16876388 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.81 | 6407741 |
| MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.85 | 12269725 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.53 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.53 | 16467112 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.27 | 15862959 16503802 |
| MESH:D013272 |
Stomach Diseases |
|
Omeprazole |
4.60 | 18545984 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
| MESH:D013276 |
Stomach Ulcer |
|
Omeprazole |
3.76 | 17977527 15991576 11906479 18237397 10750652 16755016 |
| MESH:D020521 |
Stroke |
|
Warfarin |
4.96 | 19300499 |
| MESH:D013923 |
Thromboembolism |
|
Acenocoumarol |
14.14 | 18698879 |
| MESH:D013923 |
Thromboembolism |
|
Warfarin |
14.14 | 18698879 16960144 |
| MESH:D019851 |
Thrombophilia |
|
Warfarin |
5.57 | 17493413 |
| MESH:D013927 |
Thrombosis |
|
Warfarin |
5.10 | 19300499 17245631 11518727 15720958 17672075 11307788 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.14 | 1399818 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.14 | 16026305 17045167 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.66 | 16129372 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
| MESH:D014657 |
Vasculitis |
|
Warfarin |
5.85 | 20337814 |
| MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
6.37 | 18776969 |
| MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
5.49 | 15733061 14723717 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |